Precipio, Inc. (PRPO)
22.54
+0.29
(+1.30%)
USD |
NASDAQ |
Oct 15, 16:00
22.57
+0.03
(+0.13%)
Pre-Market: 20:00
Precipio Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2017 | 0.134M |
| December 31, 2016 | 0.357M |
| September 30, 2016 | 0.393M |
| June 30, 2016 | 0.402M |
| March 31, 2016 | 0.27M |
| December 31, 2015 | 0.149M |
| September 30, 2015 | 0.561M |
| June 30, 2015 | 0.576M |
| March 31, 2015 | 0.567M |
| December 31, 2014 | 0.726M |
| September 30, 2014 | 0.641M |
| June 30, 2014 | 0.785M |
| March 31, 2014 | 0.745M |
| December 31, 2013 | 0.905M |
| September 30, 2013 | 0.63M |
| June 30, 2013 | 0.913M |
| March 31, 2013 | 0.764M |
| December 31, 2012 | 0.621M |
| September 30, 2012 | 0.668M |
| June 30, 2012 | 0.654M |
| March 31, 2012 | 0.549M |
| December 31, 2011 | 0.568M |
| September 30, 2011 | 0.515M |
| June 30, 2011 | 0.579M |
| March 31, 2011 | 0.557M |
| Date | Value |
|---|---|
| December 31, 2010 | 0.353M |
| September 30, 2010 | 0.613M |
| June 30, 2010 | 0.512M |
| March 31, 2010 | 0.827M |
| December 31, 2009 | 0.714M |
| September 30, 2009 | 0.938M |
| June 30, 2009 | 0.686M |
| March 31, 2009 | 0.844M |
| December 31, 2008 | 0.649M |
| September 30, 2008 | 0.684M |
| June 30, 2008 | 0.56M |
| March 31, 2008 | 0.572M |
| December 31, 2007 | 0.763M |
| September 30, 2007 | 0.72M |
| June 30, 2007 | 0.492M |
| March 31, 2007 | 1.058M |
| December 31, 2006 | 0.641M |
| September 30, 2006 | 0.586M |
| June 30, 2006 | 0.531M |
| March 31, 2006 | 0.604M |
| December 31, 2005 | 0.502M |
| September 30, 2005 | 0.38M |
| June 30, 2005 | 0.461M |
| March 31, 2005 | 0.606M |
| December 31, 2004 | 1.141M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NeoGenomics, Inc. | 10.76M |
| Quest Diagnostics, Inc. | -- |
| Labcorp Holdings, Inc. | -- |
| OPKO Health, Inc. | 33.17M |
| Psychemedics Corp. | -- |